Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care-Reference-Cited by-同舟云学术

Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care

Published:2017-08 Issue:8 Volume:33 Page:1036-1043
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Gulilat Markus,Tang Anthony,Gryn Steven E.,Leong-Sit Peter,Skanes Allan C.,Alfonsi Jeffrey E.,Dresser George K.,Henderson Sara L.,Rose Rhiannon V.,Lizotte Daniel J.,Teft Wendy A.,Schwarz Ute I.,Tirona Rommel G.,Kim Richard B.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Trends in prescribing oral anticoagulants in Canada, 2008-2014;Weitz;Clin Ther,2015

2. In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939—an oral, direct factor Xa inhibitor;Perzborn;J Thromb Haemost,2005

3. Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa

4. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate;Wienen;Thromb Haemost,2007

5. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Évaluation pharmaceutique des risques de prescription des anticoagulants oraux directs chez le patient atteint de cancer;Le Pharmacien Clinicien;2024-05

2. Retrospective study of clinical settings, indications and consequences of measurement of direct oral anticoagulant plasma levels in Northern Tasmania, Australia;Internal Medicine Journal;2024-01-11

3. DOAC plasma concentration upon hospital admission in a cohort of trauma patients. An observational real-life study;European Journal of Trauma and Emergency Surgery;2023-07-27

4. Personalization of Anticoagulant Therapy with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease Based on Pharmacogenetic Testing;Annals of the Russian academy of medical sciences;2023-05-24

5. Drug-drug interactions with direct oral anticoagulants for the prevention of ischemic stroke and embolism in atrial fibrillation: a narrative review of adverse events;Expert Review of Clinical Pharmacology;2023-03-07